Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver diseaseZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Pierre Broqua et al.|Journal of Hepatology|2020Cited by 163
Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as NutraceuticalZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Paloma Morata et al.|Nutrients|2020Cited by 26
A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver DiseaseZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Jaime Bosch et al.|Nutrients|2019Cited by 22